CD8 T cells utilize TRAIL to control influenza virus infection.
Elimination of influenza virus-infected cells during primary influenza virus infections is thought to be mediated by CD8(+) T cells though perforin- and FasL-mediated mechanisms. However, recent studies suggest that CD8(+) T cells can also utilize TRAIL to kill virally infected cells. Therefore, we herein examined the importance of TRAIL to influenza-specific CD8(+) T cell immunity and to the control of influenza virus infections. Our results show that TRAIL deficiency increases influenza-associated morbidity and influenza virus titers, and that these changes in disease severity are coupled to decreased influenza-specific CD8(+) T cell cytotoxicity in TRAIL(-/-) mice, a decrease that occurs despite equivalent numbers of pulmonary influenza-specific CD8(+) T cells. Furthermore, TRAIL expression occurs selectively on influenza-specific CD8(+) T cells, and high TRAIL receptor (DR5) expression occurs selectively on influenza virus-infected pulmonary epithelial cells. Finally, we show that adoptive transfer of TRAIL(+/+) but not TRAIL(-/-) CD8(+) effector T cells alters the mortality associated with lethal dose influenza virus infections. Collectively, our results suggest that TRAIL is an important component of immunity to influenza infections and that TRAIL deficiency decreases CD8(+) T cell-mediated cytotoxicity, leading to more severe influenza infections.
Brincks
Erik L
EL
Interdisciplinary Graduate Program in Immunology, University of Iowa, Iowa City, IA 52242, USA.
Katewa
Arna
A
Kucaba
Tamara A
TA
Griffith
Thomas S
TS
Legge
Kevin L
KL
D000818:Animals; D017209:Apoptosis / Q000235:genetics / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000166:cytology / Q000276:immunology* / Q000821:virology*; D002460:Cell Line; D053118:Influenza A Virus, H1N1 Subtype / Q000254:growth & development / Q000276:immunology*; D008168:Lung / Q000276:immunology / Q000473:pathology / Q000821:virology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009976:Orthomyxoviridae Infections / Q000401:mortality / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000096:biosynthesis / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D019562:Viral Load; D015431:Weight Loss / Q000235:genetics / Q000276:immunology
D053221:TNF-Related Apoptosis-Inducing Ligand; C505654:Tnfsf10 protein, mouse
J Immunol. 2000 Dec 15;165(12):6833-9
11120806
J Exp Med. 2007 Mar 19;204(3):667-80
17353365
Nat Immunol. 2001 May;2(5):381-2
11323687
J Virol. 2001 Nov;75(22):11128-36
11602752
Eur J Immunol. 2001 Nov;31(11):3138-46
11745330
Gastroenterology. 2002 Mar;122(3):659-66
11874999
Eur J Immunol. 2002 Aug;32(8):2246-54
12209637
Immunity. 2003 Feb;18(2):265-77
12594953
Nat Immunol. 2003 Apr;4(4):361-5
12640451
J Immunol. 2003 Jul 1;171(1):212-8
12817000
J Virol. 2003 Sep;77(17):9156-72
12915532
Genes Cells. 2004 Feb;9(2):165-74
15009093
J Immunol. 2004 Jul 15;173(2):1209-18
15240712
Viral Immunol. 2004;17(2):197-209
15279699
Blood. 2004 Oct 15;104(8):2418-24
15205263
J Exp Med. 1984 Sep 1;160(3):814-26
6206190
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 2):S67-71
7551417
Curr Top Microbiol Immunol. 1996;206:1-14
8608712
J Biol Chem. 1996 May 31;271(22):12687-90
8663110
J Immunol. 1996 Dec 15;157(12):5555-62
8955206
J Virol. 1998 Jan;72(1):882-5
9420305
J Immunol. 1997 Dec 1;159(11):5197-200
9548456
J Immunol. 1998 Jan 1;160(1):322-7
9551987
Eur J Immunol. 1998 May;28(5):1492-8
9603453
J Exp Med. 1999 Apr 19;189(8):1343-54
10209050
J Immunol. 1999 Jul 15;163(2):920-6
10395688
J Immunol. 2005 Jan 15;174(2):696-701
15634888
Mol Cell Biol. 2005 Mar;25(5):2000-13
15713653
J Immunol. 2005 May 1;174(9):5332-40
15843530
J Virol. 2000 Jan;74(1):556-9
10590149
J Virol. 2000 Apr;74(8):3486-93
10729122
J Immunol. 2007 Jul 1;179(1):64-70
17579022
J Virol. 2007 Sep;81(18):9790-800
17626092
J Immunol. 2008 Jan 1;180(1):25-9
18096998
J Virol. 2000 Jul;74(13):6105-16
10846094
Am J Pathol. 2001 Jan;158(1):119-30
11141485
J Virol. 2005 Jun;79(12):7658-63
15919918
J Leukoc Biol. 2005 Aug;78(2):359-71
15937142
J Exp Med. 2005 Aug 1;202(3):425-35
16061729
Cancer Biol Ther. 2005 Oct;4(10):1104-12
16096370
Immunity. 2005 Dec;23(6):649-59
16356862
J Immunol. 2006 Jan 1;176(1):248-55
16365416
Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):994-9
16418289
Nature. 2006 Oct 5;443(7111):578-81
17006449
Anticancer Res. 2006 Nov-Dec;26(6B):4115-24
17201122